TUESDAY, Feb. 25, 2025 -- There is a dose-response relationship between physical activity and rapid...
Author - David Miller
Capricor Therapeutics Completes Submission of Biologics License...
SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a...
U.S. FDA Granted Priority Review to Dizal’s Sunvozertinib...
SHANGHAI, Jan. 7, 2025 /PRNewswire/ — Dizal (SSE:688192), a biopharmaceutical company...
Serious Neurologic Complications Uncommon in Children Younger...
TUESDAY, Feb. 25, 2025 -- Serious neurologic complications are uncommon among young children with...
States That Adopted Abortion Bans Have Higher Infant Mortality
TUESDAY, Feb. 25, 2025 -- U.S. states that adopted abortion bans have higher-than-expected infant...
Atara Biotherapeutics Provides Regulatory and Business Update on...
THOUSAND OAKS, Calif.–(BUSINESS WIRE) January 16, 2025 — Atara Biotherapeutics, Inc...
Arrowhead Pharmaceuticals Announces Acceptance of New Drug...
PASADENA, Calif.–(BUSINESS WIRE)–Jan. 17, 2025– Arrowhead Pharmaceuticals, Inc. (NASDAQ:...
Stealth BioTherapeutics Announces PDUFA Action Date Extension...
NEEDHAM, Mass., Jan. 23, 2025 /PRNewswire/ — Stealth BioTherapeutics Inc. (the “Company” or...
Saol Therapeutics Announces FDA Acceptance of New Drug...
ROSWELL, Ga, DUBLIN and HAMILTON, Bermuda, January 28, 2025 – Saol Therapeutics, a privately...
Scholar Rock Submits Biologics License Application (BLA) to the...
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Jan. 29, 2025– Scholar Rock (NASDAQ: SRRK), a...